Stay updated on Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial

Sign up to get notified when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page footer/version indicator has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site release rather than a change to the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:43:09.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:20:34.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T03:28:00.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Footer Revision updated from v3.4.2 to v3.4.3; no changes to study content or data.
    Difference
    0.1%
    Check dated 2026-03-11T20:07:24.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Addition of Revision: v3.4.2 and removal of the government funding status notice appear to be site housekeeping; no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T05:43:33.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Added a site-wide government funding status notice and updated the site revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-04T05:39:20.000Z thumbnail image

Stay in the know with updates to Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.